Skip to main content

Table 6 Sensitivity Analyses of Association between FEV1/FVC and Methylation at cg02181506, cg2462102, and cg08257009, SAPALDIA Cohort

From: SERPINA1 methylation and lung function in tobacco-smoke exposed European children and adults: a meta-analysis of ALEC population-based cohorts

 

cg02181506

cg24621042

cg08257009

Coef.

P value

Coef.

P value

Coef.

P value

FEV1/FVC repeat cross-sectional

 Main modela

−0.01

0.93

0.05

0.54

0.07

0.12

 Adjustment for PiS and PiZ genotype

−0.01

0.94

0.05

0.54

0.07

0.12

 Adjustment for neutrophils at T1 and T2

−0.00

0.97

0.05

0.52

0.07

0.11

 Men

0.03

0.86

0.07

0.47

0.10

0.11

 Women

−0.07

0.65

0.06

0.62

0.05

0.49

 Not obese (BMI < 30 kg/m2)

−0.06

0.58

0.04

0.60

0.12

0.01

 Obese (BMI ≥ 30 kg/m2)

0.19

0.25

0.06

0.68

−0.12

0.14

 No self-report of ever asthma at T1 and T2

−0.03

0.78

0.07

0.35

0.08

0.09

 Asthma ever self-report at T1 or T2

0.14

0.44

−0.05

0.72

−0.01

0.88

FEV1/FVC changeb

 Main modelc

−0.01

0.60

−0.01

0.49

0.02

0.005

 Adjustment for circulating hs-crp and AATd

−0.008

0.56

−0.007

0.01

0.02

0.006

 Adjustment for PiS and PiZ genotype

−0.01

0.57

−0.01

0.48

0.02

0.005

 Adjustment for neutrophils at T1 and T2

−0.01

0.44

−0.01

0.36

0.02

0.01

 Men

0.01

0.77

−0.00

0.74

0.02

0.01

 Women

−0.03

0.14

−0.01

0.56

0.02

0.08

 Not obese (BMI < 30 kg/m2) at T1

−0.00

0.84

−0.00

0.87

0.02

0.01

 Obese (BMI ≥ 30 kg/m2) at T1

−0.04

0.13

−0.04

0.07

0.02

0.17

 No self-report of ever asthma at T1 and T2

−0.01

0.57

−0.01

0.40

0.01

0.04

 Asthma ever self-report at T1 or T2

−0.03

0.28

0.01

0.65

0.03

0.04

  1. aAdjusted for: study center, age, age2, education, height, height2, sex, sex*age, (sex*age)2, sex*height, (sex*height)2, Bcell, CD4T, CD8T, Eos, Mono, NK and ran with a random intercept on the subject
  2. bDirection of effect. A positive sign indicates that an increase in methylation is associated with higher level of lung function (cross-sectional models) and with an attenuation of lung function decline in the prediction models (change in lung function)
  3. cAdjusted for covariates at T1: study center, age, age2, education, height, height2, sex, sex*age, (sex*age)2, sex*height, (sex*height)2, Bcell, CD4T, CD8T, Eos, Mono, NK. Change in lung function was computed as the difference between T2 and T1 divided by time of follow-up: (T2-T1)/follow-up
  4. dCirculating hs-crp and AAT available from T1 only
  5. Statistically significant results are highlighted in bold